BioCurex, Inc.(fka BOCX)

[GPKOCHMAN]

Bocxan, I agree with the "secret sauce" analogy presented by tommyb. The fact that there are proprietary processes and methods that are needed in order to use RECAF technology that are not included in the patent filings, puts BOCX in the position of being able to license RECAF to a company based on the proprietary info. In essence, a company would be asking for a license to RECAF in order to obtain that knowledge. In a country where RECAF is not patented, the proprietary knowledge that goes with a license would still maintain the value of licensing agreement. If RECAF is a car then the proprietary aspect are the keys.